Back
Vishal Gulati, MD
Vishal co-founded Recode Ventures in 2022 after nearly three decades as a physician- scientist and venture capitalist. During his investment career, Vishal has backed over 40 companies developing ground-breaking treatments for unmet medical needs and has served on boards of numerous public and private companies. His work has supported the launch of innovative drugs, devices, and digital health products, impacting patients' lives in nearly 100 countries.
Vishal’s training in medicine and biomedical sciences gives him unique insight to spot which emerging technology platforms may have the potential of transforming healthcare, making him one of the early investors in successive emerging platforms such as genomics, computational biology and the convergence of imaging and machine learning.
At Recode, Vishal’s investments include Sensible Biotechnologies (novel mRNA therapeutics), Nanograb (precision gene targeting), Probably Genetic (rare disease diagnosis), Lab Genius (in-silico antibody engineering) and Waypoint Bio (spatial imaging for immuno-oncology). Some of his earlier investments include Evonetix (semiconductor platform for gene synthesis), Chemify (chemical code for drug discovery), Infinitopes (cancer vaccines), Clue (reproductive health),Ieso Digital Health (mental health, LLMs), Quit Genius (Pelego) (abuse and addiction), Zoe (microbiome), Kheiron (ML,medical imaging),Arctoris (robotics), Turbine (computational biology), Relation Therapeutics (ML/drug discovery)
Vishal’s direct investment experience includes over 15 years spent at leading venture capital firms, DFJ-Esprit (Molten Ventures), Atlas Venture and Oxford Science Enterprises. Vishal has since been invited to serve as independent chair/member of investment committees of other healthcare funds, including KHP Ventures, Cancer Research (UK) Seed Fund and University of Cambridge seed fund.
Vishal’s access and influence is expanded further by his advisory roles at the Francis Crick Institute, Reuben College, University of Oxford,British Heart Foundation, and RAND Corporation (Europe)
Vishal trained as a physician in India and continued his postgraduate training and research at the Nuffield Department of Medicine, University of Oxford and Imperial College where he also held visiting faculty position from 2003 to 2008. He is a recipient of several academic awards including two Medical Research Council fellowships, the prestigious UNESCO MCBN Fellowship and the Rhodes Scholarship.
